For silvers in their 60s, the risk of an old age blighted by Alzheimer’s Disease looks likely to be countered by treatment, says the co-chair of the government’s new dementia mission. Hilary Evans, the chief executive of Alzheimer’s Research UK, says the world is “on the cusp of a new dawn” before breakthrough drugs slow the onset of devastating neurodegenerative illness. “This could be the last generation that doesn’t have access to drugs. For those in their mid- to late 70s and 80s, it might be a bit late, by the time they’re symptomatic, for these drugs to be effective. For people in their 60s, there will, I hope, be quite a shift from where we are now.” But she warns there will need to be a major overhaul in the way people with dementia are treated – from early diagnosis onwards.